Determination of cyclosporine concentrations with monoclonal antibodies.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Clinical Chemistry

• Publication date

  1987-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/CLINCHEM/33.12.2225PMID 3319290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acquired Immune Deficiency Syndrome

  1987cited by this paper
• Potential of monoclonal antibodies to improve therapeutic monitoring of cyclosporine.

  1987cited by this paper
• Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring.

  1987influential reference
• Biotransformation and distribution in blood of cyclosporine and its metabolites.

  1986cited by this paper
• Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients.

  1986cited by this paper
• Cyclosporine metabolites in human blood and renal tissue.

  1986cited by this paper
• Cyclosporin. Bioanalytical considerations.

  1986cited by this paper
• Cyclosporine Monitoring and Pharmacokinetics in Pediatrie Liver Transplant Patients.

  1985cited by this paper
• Semi-automated high-performance liquid chromatographic method for the determination of cyclosporine in plasma and blood using column switching.

  1984cited by this paper
• Monitoring of cyclosporin A: is it possible?

  1983cited by this paper
• A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

  1981cited by this paper

• Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee

  2016cites this paper
• Immunosuppressive Drugs: Pharmacokinetics, Preanalytic Variables, and Analytical Considerations

  2008cites this paper
• Risk factors for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A

  2007cites this paper
• Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantation

  2005cites this paper
• Optimization of Protein Measurement in BIological Fluids by the Dye-Blndlng-SDS Method

  2004cites this paper
• Hyperthyroldism with Normal Values for Total Thyroxln In Serum

  2004cites this paper
• Measurement of CyclosporineConcentrationsin Whole Blood : HPLC and Radioimmunoassay with a Specific MonoclonalAntibodyand 3 Hor ‘ 251-LabeledLigandCompared

  2004influential citation
• Determinationof Cyclosponnein Plasma : SpecificRadioimmunoassaywith a Monoclonal

  2004cites this paper
• The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive Therapy

  1996cites this paper
• Cyclosporine profiles in children following renal transplantation.

  1994cites this paper
• Cyclosporine A monitoring in patients with renal, cardiac, and liver transplants: a comparison between fluorescence polarization immunoassay and two different RIA methods.

  1993cites this paper
• A Review of Assay Methods for Cyclosporin

  1992cites this paper
• Single-dose response kinetics of oral cyclosporine A: a critical reexamination.

  1992cites this paper
• Octreotide administration in the treatment of pancreatic fistulae after pancreas transplantation

  1992cites this paper
• Glia toxicity in dissociation cell cultures induced by cyclosporine.

  1992cites this paper
• Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients.

  1992cites this paper
• A review of assay methods for cyclosporin. Clinical implications.

  1992cites this paper
• A MULTICENTER STUDY TO EVALUATE A NOVEL ASSAY FOR QUANTITATION OF SOLUBLE INTERLEUKIN RECEPTOR IN RENAL TRANSPLANT RECIPIENTS

  1992cites this paper
• Maintenance Immunosuppression After Liver Transplantation

  1992cites this paper
• The Pharmacokinetics and Colonic Tissue Concentrations of Cyclosporine After IV, Oral, and Enema Administration

  1991cites this paper
• Recovery of bile secretion following orthotopic liver transplantation.

  1991cites this paper
• Measurement of cyclosporine A by a specific radioimmunoassay with a monoclonal antibody and 125I tracer.

  1991cites this paper
• Safety and Tolerability of Two Percent Cyclosporine (Sandimmune®) Ophthalmic Ointment in Normal Volunteers

  1991cites this paper
• Quality assessment of cyclosporine monitoring by 32 Canadian laboratories.

  1991cites this paper
• Monoclonal antibody technology for cyclosporine monitoring.

  1991cites this paper
• Cyclosporine monitoring by fluorescence polarization immunoassay.

  1991cites this paper
• Evaluation of Abbott TDx monoclonal assay of cyclosporine in whole blood.

  1991cites this paper
• Hyperthyroldism with Normal Values for Total Thyroxln

  1991cites this paper
• Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 2. Cross-reactivity of the antisera with cyclosporine metabolites.

  1990cites this paper
• Comparison of the utility of 3H-based specific monoclonal antibody assay on whole blood samples with the fluorescence polarization nonspecific immunoassay on serum samples for diagnosis of adverse events in renal transplant patients.

  1990cites this paper
• Area‐Under‐the‐Curve Monitoring of Cyclosporine Therapy: Performance of Different Assay Methods and Their Target Concentrations

  1990cites this paper
• Therapeutic monitoring of cyclosporine: impact of a change in standards on 125I-monoclonal RIA performance in comparison with liquid chromatography.

  1990cites this paper
• A monoclonal antibody fluorescent polarization immunoassay for cyclosporine.

  1990cites this paper
• Comparison of cyclosporin A measurement in whole blood by six different methods.

  1990cites this paper
• French multicentre study: comparison of two specific and four nonspecific methods for Sandimmune (cyclosporine) blood and plasma (separated at 37 degrees C or at 22 degrees C) monitoring.

  1990cites this paper
• Assay methods for cyclosporine monitoring following liver transplantation

  1990cites this paper
• Comparative Analyses of Cyclosporine in Whole Blood and Plasma by Radioirmmunoassay, Fluorescence Polarization Immunoassay, and High‐Performance Liquid Chromatography

  1990cites this paper
• The management of heart transplant recipients treated with cyclosporine in Ireland: Monitoring of cyclosporine concentrations in blood

  1990cites this paper
• Comparison of Four Different Cyclosporine Immunoassays in Heart and Kidney Transplant Recipients

  1990cites this paper
• The complications of newer transplant antirejection drugs: treatment with cyclosporin A, OKT3, and FK506.

  1990cites this paper
• Immuno-analyse des médicaments: concepts et applications

  1990cites this paper
• Screening for abnormal cyclosporine A metabolite concentrations.

  1989cites this paper
• Cyclosporine: a review and its specific use in liver transplantation.

  1989cites this paper
• Measurement of cyclosporine in plasma from patients with various transplants: HPLC radioimmunoassay with a specific monoclonal antibody compared.

  1989cites this paper
• Longitudinal monitoring of cyclosporine using a radioimmunoassay specific for the parent drug.

  1989cites this paper
• COMPARISON OF SPECIFIC RADIOIMMUNOASSAYS FOR CYCLOSPORINE

  1989cites this paper
• Cyclosporine kinetics in renal transplant patients as assessed by high-performance liquid chromatography and radioimmunoassay using monoclonal and polyclonal antibodies.

  1989cites this paper
• Evaluation of the Incstar Cyclo-Trac sp kit for the determination of cyclosporine in blood.

  1989cites this paper
• Cyclosporine monitoring.

  1989cites this paper
• Cyclosporine blood concentrations determined by different assay methods in heart transplant patients.

  1989cites this paper
• Measurement of cyclosporine concentrations in whole blood: HPLC and radioimmunoassay with a specific monoclonal antibody and 3H- or 125I-labeled ligand compared.

  1989cites this paper
• Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring.

  1989cites this paper
• Pharmacokinetics and pharmacodynamics of cyclosporine.

  1989cites this paper
• Cyclosporine determinations in heart and kidney transplant patients: comparison of high-performance liquid chromatography, polyclonal, and monoclonal methods.

  1989cites this paper
• Co-administration of ciprofloxacin and cyclosporin: lack of evidence for a pharmacokinetic interaction.

  1989cites this paper
• Evaluation and comparison of radioimmunoassay methods using monoclonal or polyclonal antibodies for the assay of cyclosporine in blood samples.

  1989cites this paper
• Determination of cyclosporine in plasma: specific radioimmunoassay with a monoclonal antibody and liquid chromatography compared.

  1989cites this paper
• Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies.

  1988cites this paper
• Cyclosporine: assay by HPLC and assay with monoclonal antibodies equivalent?

  1988cites this paper
• Monoclonal antibodies for radioimmunoassay of cyclosporine: a multicenter comparison of their performance with the Sandoz polyclonal radioimmunoassay kit.

  1988cites this paper
• Rapid Detection of Radioisotopicaliy Contaminated Test Serum before Radioaasay of Vitamin B 12

  year unknowncites this paper